140 related articles for article (PubMed ID: 25652703)
1. Tomography of epidermal growth factor receptor binding to fluorescent Affibody in vivo studied with magnetic resonance guided fluorescence recovery in varying orthotopic glioma sizes.
Holt RW; Demers JL; Sexton KJ; Gunn JR; Davis SC; Samkoe KS; Pogue BW
J Biomed Opt; 2015 Feb; 20(2):26001. PubMed ID: 25652703
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
[TBL] [Abstract][Full Text] [Related]
3. Dynamic dual-tracer MRI-guided fluorescence tomography to quantify receptor density in vivo.
Davis SC; Samkoe KS; Tichauer KM; Sexton KJ; Gunn JR; Deharvengt SJ; Hasan T; Pogue BW
Proc Natl Acad Sci U S A; 2013 May; 110(22):9025-30. PubMed ID: 23671066
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography-guided time-domain diffuse fluorescence tomography in small animals for localization of cancer biomarkers.
Tichauer KM; Holt RW; Samkoe KS; El-Ghussein F; Gunn JR; Jermyn M; Dehghani H; Leblond F; Pogue BW
J Vis Exp; 2012 Jul; (65):e4050. PubMed ID: 22847515
[TBL] [Abstract][Full Text] [Related]
5. MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors.
Davis SC; Samkoe KS; O'Hara JA; Gibbs-Strauss SL; Payne HL; Hoopes PJ; Paulsen KD; Pogue BW
Acad Radiol; 2010 Mar; 17(3):271-6. PubMed ID: 20152724
[TBL] [Abstract][Full Text] [Related]
6. Comparing implementations of magnetic-resonance-guided fluorescence molecular tomography for diagnostic classification of brain tumors.
Davis SC; Samkoe KS; O'Hara JA; Gibbs-Strauss SL; Paulsen KD; Pogue BW
J Biomed Opt; 2010; 15(5):051602. PubMed ID: 21054076
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent affibody peptide penetration in glioma margin is superior to full antibody.
Sexton K; Tichauer K; Samkoe KS; Gunn J; Hoopes PJ; Pogue BW
PLoS One; 2013; 8(4):e60390. PubMed ID: 23593208
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
9. Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma.
Shazeeb MS; Sotak CH; DeLeo M; Bogdanov A
Cancer Res; 2011 Mar; 71(6):2230-9. PubMed ID: 21245103
[TBL] [Abstract][Full Text] [Related]
10. Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas.
Gibbs-Strauss SL; Samkoe KS; O'Hara JA; Davis SC; Hoopes PJ; Hasan T; Pogue BW
Acad Radiol; 2010 Jan; 17(1):7-17. PubMed ID: 19796971
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive quantification of target availability during therapy using paired-agent fluorescence tomography.
Meng B; Folaron MR; Strawbridge RR; Sadeghipour N; Samkoe KS; Tichauer K; Davis SC
Theranostics; 2020; 10(24):11230-11243. PubMed ID: 33042280
[TBL] [Abstract][Full Text] [Related]
12. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.
Miao Z; Ren G; Liu H; Jiang L; Cheng Z
J Biomed Opt; 2010; 15(3):036007. PubMed ID: 20615009
[TBL] [Abstract][Full Text] [Related]
13. Accounting for pharmacokinetic differences in dual-tracer receptor density imaging.
Tichauer KM; Diop M; Elliott JT; Samkoe KS; Hasan T; St Lawrence K; Pogue BW
Phys Med Biol; 2014 May; 59(10):2341-51. PubMed ID: 24743262
[TBL] [Abstract][Full Text] [Related]
14. Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents.
Habimana-Griffin L; Ye D; Carpenter J; Prior J; Sudlow G; Marsala L; Mixdorf M; Rubin J; Chen H; Achilefu S
J Biomed Opt; 2020 Feb; 25(2):1-13. PubMed ID: 32112540
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic detection of diffuse glioma tumors in vive with molecular fluorescent probe-based transmission spectroscopy.
Gibbs-Strauss SL; O'Hara JA; Srinivasan S; Hoopes PJ; Hasan T; Pogue BW
Med Phys; 2009 Mar; 36(3):974-83. PubMed ID: 19378758
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Glioma Detection Using an EGFR-Targeted Fluorescent Affibody.
Ribeiro de Souza AL; Marra K; Gunn J; Samkoe KS; Hull S; Paulsen KD; Pogue BW
Photochem Photobiol; 2018 Nov; 94(6):1167-1171. PubMed ID: 30129069
[TBL] [Abstract][Full Text] [Related]
17. An optical probe for noninvasive molecular imaging of orthotopic brain tumors overexpressing epidermal growth factor receptor.
Agnes RS; Broome AM; Wang J; Verma A; Lavik K; Basilion JP
Mol Cancer Ther; 2012 Oct; 11(10):2202-11. PubMed ID: 22807580
[TBL] [Abstract][Full Text] [Related]
18. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer.
Buckle T; van Willigen DM; Spa SJ; Hensbergen AW; van der Wal S; de Korne CM; Welling MM; van der Poel HG; Hardwick JCH; van Leeuwen FWB
J Nucl Med; 2018 Jun; 59(6):986-992. PubMed ID: 29449447
[TBL] [Abstract][Full Text] [Related]
19. [The anti-cancer effect of ZR30 protein via targeting extracellular signal proteins of different cell subpopulations of glioma].
Li YY; Chen XH; Sun T; Hu Y; Zhou YH; Zhou YX
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):812-817. PubMed ID: 30481930
[No Abstract] [Full Text] [Related]
20. In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore.
Gong H; Kovar J; Little G; Chen H; Olive DM
Neoplasia; 2010 Feb; 12(2):139-49. PubMed ID: 20126472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
